Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...
Artificial intelligence and machine learning can help overcome poor solubility and bioavailability. Artificial intelligence (AI) and machine learning (ML) in the biopharmaceutical industry have been ...
A biotech company based in Spain is using new formulations to deliver larger molecules to the respiratory system.
BOSTON--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending ...
SugarMDs is thrilled to announce the highly anticipated return of its Advanced Glucose Support formula, available for purchase starting February 12th. With an improved formulation and an ...
CD Formulation, a leading force in biotechnology research and development, is at the forefront of revolutionizing transdermal delivery systems. As the demand for non-invasive, efficient drug delivery ...
Alexion Pharmaceuticals Inc. ALXN announced that the FDA has approved a new advanced formulation of Ultomiris (ravulizumab-cwvz). The FDA approved Ultomiris100 mg/mL formulation for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback